PATENT CLAIM ANALYSIS

Application Number: 15967765
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["424", "152100"]

Abstract:
There is provided agents for modulation of a chronic inflammatory response wherein the agent modulates the biological activity of tenascin-C. There is also provided methods of identifying agents modulating tenascin-C and chronic inflammation. There are also provided uses of such agents.

Claim (Index 2):
The method of  claim 1 , wherein the agent modulates the biological activity of tenascin-C by altering the binding properties of tenascin-C.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.57143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15109775', '15501979', '13813179', '14520904', '15632882']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7080616292775596
- 35 USC 102 Novelty (BERT): 0.5777379500436045
- Combined Prediction Score: 0.695029261354164
- Mean Citation Score: 309.67203
- Max Citation Score: 508.75275
- Similarity Product: 345.63538176968694

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test